Insulin aspart, recombinant Subcutaneous and Myxredlin Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Myxredlin Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: insulin regular
Brand name: Humulin R, Myxredlin, Novolin R, HumuLIN R KwikPen
Synonyms: Insulin Regular
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Myzilra
- Myxredlin Injection-Insulin degludec
- Myxredlin Injection-Insulin Degludec (U-100) Prefilled Pens
- Myxredlin Injection-Insulin Degludec (U-100) Vials
- Myxredlin Injection-Insulin Degludec (U-200) Prefilled Pens
- Myxredlin Injection-Insulin degludec and liraglutide
- Myxredlin Injection-Insulin degludec and liraglutide Subcutaneous